Table 3.
STG BI (n = 36) |
STG BII (n = 16) |
TG (n = 12) |
|||||||
3 mo | 6 mo | 12 mo | 3 mo | 6 mo | 12 mo | 3 mo | 6 mo | 12 mo | |
Stationary | 16 (44.4) | 16 (44.4) | 15 (41.7) | 8 (50) | 8 (50) | 6 (37.5) | 6 (50) | 7 (58.3) | 6 (50) |
Improved | 19 (52.8) | 20 (62.5) | 21 (58.3) | 8 (50) | 8 (50) | 9 (56.2) | 6 (50) | 4 (33.3) | 5 (41.7) |
Remission | 1 (2.8) | 0 | 0 | 0 | 0 | 1 (6.2) | 0 | 1 (8.3) | 1 (8.3) |
Medication stopped | 6 (16.7) | 6 (16.7) | 6 (16.7) | 2 (12.5) | 2 (12.5) | 4 (25) | 3 (25) | 3 (25) | 3 (25) |
Stationary: No change in medication, or patients except improved and remission criteria; Improved: Reduced medication and a reduction in fasting blood glucose (FBS) or HbA1c; Remission: No medication and FBS < 126 mg/dL and HbA1c < 6.0%. STG BI: Subtotal gastrectomy with Billroth I anastomosis; STG BII: Subtotal gastrectomy with Billroth II anastomosis; TG: Total gastrectomy.